Olanzapine

Salveo®

Prescription Drug

Indications

•    Schizophrenia

• Acute and maintenance treatment of schizophrenia and related psychoses in adults and adolescents (13 to 17 years old)

•    Bipolar I Disorder (Manic or Mixed Episodes)

• As monotherapy for the acute and maintenance treatment of manic or mixed episodes associated with Bipolar I Disorder in adults and adolescents (13 to 17 years old)
• Adjunct to valproate or lithium in the treatment of manic episodes associated with Bipolar I Disorder in adults
• For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

•    In combination with fluoxetine:

• Acute treatment of depressive episodes associated with Bipolar I Disorder in adults ad children (10 to 17 years old)

Olanzapine monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder.

• Acute treatment of treatment-resistant depression in adults (major depressive disorder in patients who do not respond to two separate trials of different antidepressants of adequate dose and duration in the current episode)

Olanzapine monotherapy is not indicated for the treatment of treatment-resistant depression.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.